CN111643630A - 一种五行艾中药组合物 - Google Patents
一种五行艾中药组合物 Download PDFInfo
- Publication number
- CN111643630A CN111643630A CN202010694407.4A CN202010694407A CN111643630A CN 111643630 A CN111643630 A CN 111643630A CN 202010694407 A CN202010694407 A CN 202010694407A CN 111643630 A CN111643630 A CN 111643630A
- Authority
- CN
- China
- Prior art keywords
- fructus
- powder
- glycyrrhrizae radix
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 72
- 239000003814 drug Substances 0.000 claims abstract description 23
- 241000229143 Hippophae Species 0.000 claims abstract description 14
- 235000003935 Hippophae Nutrition 0.000 claims abstract description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 12
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 12
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 12
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 12
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 12
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 12
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 12
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 12
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 12
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 12
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 12
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 8
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 8
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 8
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 8
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000009609 fructus phyllanthi Substances 0.000 claims abstract description 7
- 235000011477 liquorice Nutrition 0.000 claims abstract description 7
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- 244000248825 Peltandra virginica Species 0.000 claims description 3
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 3
- 235000008599 Poria cocos Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000005096 rolling process Methods 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 240000001851 Artemisia dracunculus Species 0.000 claims 6
- 230000000694 effects Effects 0.000 abstract description 42
- 240000000950 Hippophae rhamnoides Species 0.000 abstract description 8
- 235000003145 Hippophae rhamnoides Nutrition 0.000 abstract description 8
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract description 7
- 235000017784 Mespilus germanica Nutrition 0.000 abstract description 6
- 235000000560 Mimusops elengi Nutrition 0.000 abstract description 6
- 235000008708 Morus alba Nutrition 0.000 abstract description 6
- 240000000249 Morus alba Species 0.000 abstract description 6
- 235000007837 Vangueria infausta Nutrition 0.000 abstract description 6
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 abstract description 5
- 244000185386 Thladiantha grosvenorii Species 0.000 abstract description 5
- 210000001835 viscera Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 235000010894 Artemisia argyi Nutrition 0.000 abstract description 3
- 244000030166 artemisia Species 0.000 abstract description 3
- 240000006891 Artemisia vulgaris Species 0.000 abstract description 2
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 22
- 210000003734 kidney Anatomy 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- 210000000952 spleen Anatomy 0.000 description 19
- 230000001737 promoting effect Effects 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 14
- 206010011224 Cough Diseases 0.000 description 13
- 210000002216 heart Anatomy 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 206010062717 Increased upper airway secretion Diseases 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 10
- 208000026435 phlegm Diseases 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 5
- 240000002624 Mespilus germanica Species 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 230000000975 bioactive effect Effects 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 229940010454 licorice Drugs 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000007443 Neurasthenia Diseases 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000234435 Lilium Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 235000011034 Rubus glaucus Nutrition 0.000 description 3
- 235000009122 Rubus idaeus Nutrition 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000009098 adjuvant therapy Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 210000002249 digestive system Anatomy 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000007215 black sesame Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000019525 fullness Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 210000004994 reproductive system Anatomy 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 244000141331 Amomum villosum Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000317410 Arisaema dracontium Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010059186 Early satiety Diseases 0.000 description 1
- 244000119298 Emblica officinalis Species 0.000 description 1
- 235000015489 Emblica officinalis Nutrition 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000009815 Momordica Nutrition 0.000 description 1
- 241000218984 Momordica Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000001533 respiratory mucosa Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000009396 suanzaoren Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种五行艾中药组合物,包括罗汉果粉、枸杞桑葚粉、佛手粉、砂仁山楂粉、沙棘甘草粉和艾绒;罗汉果粉包括25‑30%罗汉果、30‑40%百合、20‑30%甘草和2‑15%山药;枸杞桑椹粉包括25‑35%枸杞子、30‑40%桑椹子、20‑25%山药、5‑10%覆盆子、5‑15%余甘子;佛手粉包括15‑30%佛手、20‑25%枸杞子、10‑32%甘草、10‑25%山楂、10‑20%砂仁;砂仁山楂粉包括10‑15%砂仁、30‑40%山楂、15‑25%茯苓、15‑20%山药、5‑10%甘草、5‑16%陈皮;沙棘甘草粉包括由30‑40%沙棘粉、15‑20%甘草、15‑26%枸杞子、10‑16%黑芝麻、5‑15%酸枣仁。本发明采用上述一种五行艾中药组合物,无毒副作用,可以实现同时对五脏进行养护。
Description
技术领域
本发明涉及艾灸技术领域,特别是涉及一种五行艾中药组合物。
背景技术
艾灸产生于中国远古时代,是用艾叶制成的艾灸材料产生的艾热刺激体表穴位或特定部位,通过激发经气的活动来调整人体紊乱的生理功能,从而达到防治疾病和养生保健的目的。
艾灸因为具有祛风散寒和通经活络的功效被广泛应用于医疗领域,但是现今的艾灸配方比较单一,大量的艾灸只由单一的艾绒支撑,这样的老式艾灸因为加入的辅助材料少致使治疗效果并不理想。不同的中药配方针对不同的病症,而市场上还没有出现从五行的角度对人体五脏进行养护的养生艾灸。
发明内容
本发明的目的是提供一种五行艾中药组合物,无毒副作用,可以实现同时对五脏进行养护。
为实现上述目的,本发明提供了一种五行艾中药组合物,包括罗汉果粉、枸杞桑葚粉、佛手粉、砂仁山楂粉、沙棘甘草粉和艾绒;
罗汉果粉包括25-30%罗汉果、30-40%百合、20-30%甘草和2-15%山药;枸杞桑椹粉包括25-35%枸杞子、30-40%桑椹子、20-25%山药、5-10%覆盆子、5-15%余甘子;佛手粉包括15-30%佛手、20-25%枸杞子、10-32%甘草、10-25%山楂、10-20%砂仁;砂仁山楂粉包括10-15%砂仁、30-40%山楂、15-25%茯苓、15-20%山药、5-10%甘草、5-16%陈皮;沙棘甘草粉包括由30-40%沙棘粉、15-20%甘草、15-26%枸杞子、10-16%黑芝麻、5-15%酸枣仁。
优选的,罗汉果粉包括30%罗汉果、40%百合、25%甘草和5%山药。
优选的,枸杞桑椹粉包括30%枸杞子、40%桑椹子、20%山药、5%覆盆子、5%余甘子。
优选的,佛手粉包括20%佛手、20%枸杞子、30%甘草、10%山楂、20%砂仁。
优选的,砂仁山楂粉包括10%砂仁、35%山楂、20%茯苓、20%山药、6%甘草、9%陈皮。
优选的,沙棘甘草粉包括40%沙棘粉、20%甘草、15%枸杞子、12%黑芝麻、13%酸枣仁。
优选的,五行艾中药组合物制备方法为将各中药组分份称量后与艾绒混合,卷制成艾条。
本发明的各组分作用效果如下:
罗汉果味甘、酸,性凉,入肺、大肠经,有清热凉血、生津止渴、止咳平喘、润肺化痰等功效,可用于治疗痰热咳嗽、咽喉肿痛、急性气管炎等症。罗汉果含有丰富的糖甙,具有降血糖作用,可以用来辅助治疗糖尿病;另含丰富的维生素C、果糖及黄酮等营养素,有抗衰老、止咳化痰、防癌抗癌及嫩肤美容作用;还具有降血脂、减肥作用,可辅助治疗高脂血症,防治肥胖。
百合味苦、性寒,入心、肺经,可养阴润肺,清心安神,养胃和中。用于阴虚久咳、痰中带血、虚热烦躁、惊悸、失眠多梦、精神恍惚等症。百合有良好的营养滋补之功,特别是对呼吸系统疾病、病后体虚、神经衰弱等症大有裨益。百合所含成分对肿瘤细胞有较强抑制作用,临床上可用于白血病、肺癌、皮肤癌、鼻咽癌、乳腺癌、宫颈癌的辅助治疗。
甘草味甘,性平,入心、肺、脾、胃经。可补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。常用于治疗咳嗽痰多、脾胃虚弱、倦怠乏力、心悸气短、腹痛、四肢痉挛疼痛、痈肿疮毒等症。甘草主要成分有甘草酸、甘草甙等,有显著的促进肾上腺皮激素样作用,可用于人体抗衰老、抗炎症、降压、增强机体免疫力、提高生理机能、维持水盐代谢平衡等方面。
山药味甘,性平。入脾、肺、肾经,可生津益肺、补脾养胃、补肾固精。常用于肺虚喘咳、脾虚食少、久泻不止、肾虚遗精、带下、尿频、虚热消渴等症。山药富含多种营养成分,对白细胞吞噬功能有促进作用。
枸杞子味甘,性平,入肝、肾经。可滋补肝肾,益精明目。常用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。枸杞子对老年肝肾虚损有显著的保健和治疗作用。
桑椹子味甘、酸,性寒,入心、肝、肾经。可滋补肝肾、补血养颜、生津止渴。用于治疗肝肾阴亏、腰膝酸软、目暗耳鸣、须发早白、关节不利、津亏血少、口渴烦热、肠燥便秘、糖尿病、高血压、动脉硬化等病症。桑椹子含有活性多糖、黄酮类物质和芦丁等生物活性成份、多种人体必需的氨基酸、容易人体吸收的果糖和葡萄糖,并含有多种维生素及铁、钙、锌等矿物元素,硒等微量元素等营养素。
覆盆子味甘、酸,性温,入肝、肾经,可益肾,固精,缩尿。常用于肾虚遗尿、小便频数、阳痿早泄、遗精滑精等症。覆盆子富含有机酸、多糖、B-谷甾醇等生物活性成分,且含有丰富的锰、锌等微量元素。覆盆子可抗衰老,且对生殖系统、免疫系统均有显著的调节作用。
余甘子其性凉,味甘微涩,归肺、胃经,有清肺热、生津液之功能。可用于治疗外感风热、口渴咽干、咳嗽痰多、急慢性咽喉炎,还可以治疗肠炎痢疾、哮喘、支气管炎、乙肝、糖尿病等症。余甘子可增强人体免疫力,并能有效阻断体内致癌物质的合成,具有很好地防癌治癌作用;且独具降脂、调脂双重功效,标本兼治,可从根本上提高人体脂类分解能力,平衡代谢。
佛手味苦、辛,性温,入肝、脾、肺经。可舒肝理气,和胃止痛。常用于肝胃气滞,胸胁胀痛,胃脘痞满,食少呕吐。
砂仁味辛,性温,入脾、胃、肾经。可化湿行气,温脾止泻,安胎。常用于胸脘痞闷、脾胃虚寒、食积不消、呕吐泄泻、妊娠恶阻、胎动不安等症。砂仁富含挥发油,对人体具有明显的保健作用:可促进胃肠蠕动,增强消化吸收功能,防治应激性溃疡,并可增强人体免疫功能,激活机体的抗癌防御能力,抑制肿瘤生长和扩散,并能起延年益寿之功效。
山楂味甘酸,性平,入脾、胃、肝经。可消食积,散瘀血,驱绦虫。主治肉积,积聚,痰饮,上腹胀满,返酸,泻痢,肠风,腰痛,疝气,恶露不尽,小儿饮食停滞,产后瘀滞腹痛等病症。山楂对消化系统、心脑血管系统均有良好的调节作用,能够促进消化吸收、扩张冠状动脉、舒张血管、增加血流量,改善心脏活力、兴奋中枢神经系统,并具有降脂、降压、强心、抗心律不齐、防癌抗癌、抗炎杀菌等作用。
茯苓味甘淡,性平,入心、脾、肺经,既有滋补强身作用,又有渗湿利水、益脾和胃、宁心安神、开心益智之功。茯苓药性缓和,补而不峻,利而不猛。既能扶正,有可祛邪。茯苓能直接抑制肿瘤细胞的生长外,尚具有提高巨噬细胞的吞噬功能,促进免疫球蛋白形成等免疫增强作用。茯苓还具有增强心肌收缩力,保护肝脏,防止肝细胞坏死,以及利水、降低血糖、镇静、抑菌、美容养颜、抗衰老等作用。
陈皮性温,味苦、辛,入脾、肺经,可理气健脾,燥湿化痰,疏肝和胃最为见长。常用于胸腹胀满、食少吐泻、咳嗽多痰、上腹痛、腹胀、早饱、反酸、烧心、恶心、呕吐等症。陈皮富含柠檬烯挥发油、黄酮甙、胡萝卜素等营养素,可缓和消化道刺激,有利于胃肠积气的排出,促进胃液分泌,有助于消化吸收。也能刺激呼吸道粘膜,使其分泌物增多,痰液稀释,有利于排出,并有抗菌消炎作用。
沙棘味酸、涩,性温,可止咳祛痰、消食化滞、活血散瘀。沙棘可有效改善心脑血液循环,对冠心病、心绞痛、心律失常、心肌缺血、高血脂等病症效果显著,对脑血管疾病也有预防和治疗作用。还能降低血液粘稠度,增强血管韧性,加快血流,降低和清除体内氧自由基。
黑芝麻味甘、性平,入肝、肾经。可补肝肾,益精血,润肠燥。芝麻中的维生素E非常丰富,可延缓衰老、美容养颜。其所含的各种营养素可润五脏、强筋骨、益气力、滋补肝肾、润养脾肺,对肺阴虚所致干咳、高血压、心脑血管动脉硬化、神经衰弱、皮肤干燥及胃肠阴虚所致的便秘、产后阴血不足所致的乳少、等症均有很好的疗效。
酸枣仁味甘、酸,性平。入心、肝经。可养心,安神,敛汗。常用于神经衰弱、心悸、失眠、多梦、盗汗等症。酸枣仁富含酸枣仁皂甙、白桦脂酸、白桦脂醇、黄酮等生物活性物质及脂肪油、蛋白质等多种营养素。酸枣仁所含各类营养物质有良好的镇静、催眠作用及滋养强壮作用。尤其适用于神经衰弱、神经官能症、心脏病等疾病患者。
本发明中白虎罗汉果粉调养肺,玄武枸杞桑葚粉调养肾,青龙佛手粉调养肝,金凤砂仁山楂粉调养脾,朱雀沙棘甘草粉调养心。罗汉果粉养阴清肺、止咳化痰、益气平喘、润肠通便,对呼吸系统起到特别滋养作用。枸杞桑葚粉补充多种具有滋养肝肾、养血明目、固肾涩精、益气生津作用的多种生物活性成分,及多种人体营养必需氨基酸、维生素、微量元素等天然营养素,对肝肾、生殖系统、造血系统、免疫系统进行特别滋养。佛手粉舒肝理气、健脾养胃、消食化积,对肝胆、胃肠等消化器官进行滋养,使机体保持平衡健康状态。砂仁山楂粉健脾养胃、消食化积、开郁导滞,对消化系统起到特别的滋养作用。沙棘甘草粉补充具有活血化瘀、养心益肾、润肺止咳、健脾养胃作用的多种生物活性物质,及大量维生素、氨基酸等营养素,可对循环系统、呼吸系统、消化系统、神经系统产生良好的营养作用。通过综合五行综合补充,实现机体保持平衡健康状态。
下面通过实施例,对本发明的技术方案做进一步的详细描述。
具体实施方式
下面对本发明的实施方式做进一步的说明。
一种五行艾中药组合物,包括罗汉果粉、枸杞桑葚粉、佛手粉、砂仁山楂粉、沙棘甘草粉和艾绒;
罗汉果粉包括25-30%罗汉果、30-40%百合、20-30%甘草和2-15%山药;枸杞桑椹粉包括25-35%枸杞子、30-40%桑椹子、20-25%山药、5-10%覆盆子、5-15%余甘子;佛手粉包括15-30%佛手、20-25%枸杞子、10-32%甘草、10-25%山楂、10-20%砂仁;砂仁山楂粉包括10-15%砂仁、30-40%山楂、15-25%茯苓、15-20%山药、5-10%甘草、5-16%陈皮;沙棘甘草粉包括由30-40%沙棘粉、15-20%甘草、15-26%枸杞子、10-16%黑芝麻、5-15%酸枣仁。
五行艾中药组合物制备方法为将各中药组分份称量后与艾绒混合,卷制成艾条。
实施例一
罗汉果粉包括30%罗汉果、40%百合、25%甘草和5%山药。
实施例二
枸杞桑椹粉包括30%枸杞子、40%桑椹子、20%山药、5%覆盆子、5%余甘子。
实施例三
佛手粉包括20%佛手、20%枸杞子、30%甘草、10%山楂、20%砂仁。
实施例四
砂仁山楂粉包括10%砂仁、35%山楂、20%茯苓、20%山药、6%甘草、9%陈皮。
实施例五
沙棘甘草粉包括40%沙棘粉、20%甘草、15%枸杞子、12%黑芝麻、13%酸枣仁。
因此,本发明采用上述一种五行艾中药组合物,无毒副作用,可以实现同时对五脏进行养护。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进,这些改进也应视为本发明的保护范围。
Claims (7)
1.一种五行艾中药组合物,其特征在于:包括罗汉果粉、枸杞桑葚粉、佛手粉、砂仁山楂粉、沙棘甘草粉和艾绒;
罗汉果粉包括25-30%罗汉果、30-40%百合、20-30%甘草和2-15%山药;枸杞桑椹粉包括25-35%枸杞子、30-40%桑椹子、20-25%山药、5-10%覆盆子、5-15%余甘子;佛手粉包括15-30%佛手、20-25%枸杞子、10-32%甘草、10-25%山楂、10-20%砂仁;砂仁山楂粉包括10-15%砂仁、30-40%山楂、15-25%茯苓、15-20%山药、5-10%甘草、5-16%陈皮;沙棘甘草粉包括由30-40%沙棘粉、15-20%甘草、15-26%枸杞子、10-16%黑芝麻、5-15%酸枣仁。
2.根据权利要求1所述的一种五行艾中药组合物,其特征在于;罗汉果粉包括30%罗汉果、40%百合、25%甘草和5%山药。
3.根据权利要求1所述的一种五行艾中药组合物,其特征在于:枸杞桑椹粉包括30%枸杞子、40%桑椹子、20%山药、5%覆盆子、5%余甘子。
4.根据权利要求1所述的一种五行艾中药组合物,其特征在于:佛手粉包括20%佛手、20%枸杞子、30%甘草、10%山楂、20%砂仁。
5.根据权利要求1所述的一种五行艾中药组合物,其特征在于:砂仁山楂粉包括10%砂仁、35%山楂、20%茯苓、20%山药、6%甘草、9%陈皮。
6.根据权利要求1所述的一种五行艾中药组合物,其特征在于:沙棘甘草粉包括40%沙棘粉、20%甘草、15%枸杞子、12%黑芝麻、13%酸枣仁。
7.根据权利要求1所述的一种五行艾中药组合物,其特征在于:五行艾中药组合物制备方法为将各中药组分份称量后与艾绒混合,卷制成艾条。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010694407.4A CN111643630A (zh) | 2020-07-17 | 2020-07-17 | 一种五行艾中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010694407.4A CN111643630A (zh) | 2020-07-17 | 2020-07-17 | 一种五行艾中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111643630A true CN111643630A (zh) | 2020-09-11 |
Family
ID=72340669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010694407.4A Pending CN111643630A (zh) | 2020-07-17 | 2020-07-17 | 一种五行艾中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111643630A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742971A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 砂仁山楂冲剂及其制备工艺 |
CN1742970A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 佛手片及其制备工艺 |
CN1742626A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 沙棘甘草片及其制备工艺 |
CN1742927A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 枸杞桑椹片及其制备工艺 |
CN1757317A (zh) * | 2005-09-17 | 2006-04-12 | 张志祥 | 罗汉果片及其制备工艺 |
-
2020
- 2020-07-17 CN CN202010694407.4A patent/CN111643630A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742971A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 砂仁山楂冲剂及其制备工艺 |
CN1742970A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 佛手片及其制备工艺 |
CN1742626A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 沙棘甘草片及其制备工艺 |
CN1742927A (zh) * | 2005-09-17 | 2006-03-08 | 张志祥 | 枸杞桑椹片及其制备工艺 |
CN1757317A (zh) * | 2005-09-17 | 2006-04-12 | 张志祥 | 罗汉果片及其制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104256616B (zh) | 一种改善特禀体质的食品及其制备工艺 | |
CN103263608B (zh) | 一种排毒养颜的中药原粉 | |
CN113521243A (zh) | 一种改善人体微循环的中药组合物及制备方法 | |
CN102614444A (zh) | 一种有效治疗酒醉综合症的口服液 | |
CN103007107B (zh) | 一种调理产后虚弱症的中药制剂 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN104673597A (zh) | 一种多功能养生酒及其制作方法 | |
CN104491400A (zh) | 一种化疗后调补的中药药膳配方及其制备方法 | |
CN104474487A (zh) | 补脾和胃酒 | |
CN107998366A (zh) | 一种适用于产后初期产妇催乳的中药组合物及其制备方法 | |
CN111643630A (zh) | 一种五行艾中药组合物 | |
CN102895392B (zh) | 一种治疗十二指肠溃疡的中药 | |
CN106177437B (zh) | 一种改善女性阳虚体寒的玛咖组合物 | |
CN104825777A (zh) | 一种具有补气安神功效的保健胶囊及制备方法 | |
CN104740415A (zh) | 一种治疗哺乳期女性骨质疏松症的中药制剂 | |
CN1336216A (zh) | 一种治疗胃病的药物及其应用 | |
CN103463463A (zh) | 一种补血活血、祛风除湿的中药制剂 | |
CN108355054A (zh) | 一种养生药酒 | |
CN114569687B (zh) | 一种中药制剂的配方 | |
CN106266540A (zh) | 用于治疗女性宫寒的药物 | |
CN105125855A (zh) | 一种配合肿瘤化疗的中药组合物 | |
CN104825879A (zh) | 临床护理用健脾补肾胶囊及制备方法 | |
CN105106600A (zh) | 一种促进因车祸致脑部外伤手术后愈合的组合物及制法 | |
CN117618517A (zh) | 一种pqq抗衰鹿鞭养生中药组合物 | |
CN105031562A (zh) | 活血润燥酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200911 |